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The Hedgehog (Hh) signaling pathway regulates tis-
sue patterning during development, including pat-
terning and growth of limbs and face, but whether Hh
signaling plays a role in adult kidney remains unde-
fined. In this study, using a panel of hedgehog-re-
porter mice, we show that the two Hh ligands (Indian
hedgehog and sonic hedgehog ligands) are expressed
in tubular epithelial cells. We report that the Hh ef-
fectors (Gli1 and Gli2) are expressed exclusively in
adjacent platelet-derived growth factor receptor--
positive interstitial pericytes and perivascular fibro-
blasts, suggesting a paracrine signaling loop. In two
models of renal fibrosis, Indian Hh ligand was up-
regulated with a dramatic activation of downstream
Gli effector expression. Hh-responsive Gli1-positive
interstitial cells underwent 11-fold proliferative ex-
pansion during fibrosis, and both Gli1- and Gli2-pos-
itive cells differentiated into -smooth muscle actin-
positive myofibroblasts. In the pericyte-like cell line
10T1/2, hedgehog ligand triggered cell proliferation,
suggesting a possible role for this pathway in the
regulation of cell cycle progression of myofibroblast
progenitors during the development of renal fibrosis.
The hedgehog antagonist IPI-926 abolished Gli1 in-
duction in vivo but did not decrease kidney fibrosis.
However, the transcriptional induction of Gli2 was
unaffected by IPI-926, suggesting the existence of
smoothened-independent Gli activation in thismodel. This study is the first detailed description of
paracrine hedgehog signaling in adult kidney, which
indicates a possible role for hedgehog-Gli signaling in
fibrotic chronic kidney disease. (Am J Pathol 2012, 180:
1441–1453; DOI: 10.1016/j.ajpath.2011.12.039)
The Hedgehog (Hh) signaling pathway plays a crucial
role in regulating a diverse range of developmental pro-
cesses in the mammalian embryo, including ventraliza-
tion of the neural tube, patterning and growth of limbs
and face, the formation of organs (such as the lung and
gut), development of hair follicles, and decisions of left-
right asymmetry.1,2 In the kidney, sonic hedgehog (Shh)
expression in papillary collecting duct and ureteric epi-
thelium regulates adjacent mesenchymal cell prolifera-
tion and differentiation, and either germline Shh deletion
or deletion of Shh from collecting duct leads to severe
renal developmental abnormalities, including renal apla-
sia or hypoplasia.3–5 Mutations affecting the Hh signaling
member Gli3 in humans with Pallister-Hall syndrome are
associated with renal malformation, further implicating Hh
in human renal morphogenesis.6,7
Three Hh ligands are found in mice and humans: 1)
Shh, 2) desert hedgehog (Dhh), and 3) Indian hedgehog
(Ihh) ligands.1 These secreted, lipid-modified proteins
can act at short or long distances by binding to the
membrane receptor Patched1 (Ptch1) on target cells,
thereby releasing tonic inhibition by Ptch1 on the trans-
membrane protein smoothened (Smo). Derepressed
Smo translocates to the primary cilium, inhibiting produc-
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transcription factors and promoting preservation of their
full-length activator forms, which induce transcription of
Hh target genes, including Gli1 and Ptch1, both of which
serve as readouts of Hh pathway activation.8 Hh signal-
ing has multiple, context-dependent downstream effects,
such as controlling expression of patterning genes (ie,
Pax2 and Sall1) or regulating cell cycle by activating
Cyclin D1 and N-Myc.5
Little is known about a role for the Hh pathway in the adult
kidney. In cancer and solid organ injury models, recent
evidence suggests that epithelial-derived Hh ligands can
be reactivated in pathological states to transmit signals to
surrounding mesenchymal cells. For example, in carcino-
genesis, Hh ligands from the epithelial tumor act on adja-
cent stroma to promote a favorable tumor microenviron-
ment.9–11 In murine bladder injury, epithelial Shh induces
Wnt expression in surrounding stromal cells, which in turn
stimulates stromal and epithelial proliferation in a para-
crine signaling loop.12 Hh pathway reactivation has also
been implicated in organ fibrosis. Both chronic cholesta-
sis and nonalcoholic steatohepatitis are characterized by
increased Hh signaling during fibrosis,13,14 and Hh sig-
naling promotes activation of hepatic stellate cells to the
myofibroblastic phenotype.15 In lung fibrosis, Shh is up-
regulated in airway epithelial cells, and Ptch1 expression
is increased in the pulmonary interstitium.16 Collectively,
these observations suggest that mesenchymal cells may
be targets of Hh signaling in pathological states, just as
they are in development.
Myofibroblasts (the scar forming cells in fibrosis) de-
rive from mesenchymal progenitors in the kidney,17,18
and because of this, we hypothesized that the Hh path-
way would be activated in these cells during renal fibro-
genesis. Using complementary techniques, including a
variety of genetic reporter mice, we demonstrate that the
Hh ligands (Ihh and Shh) are expressed in tubular epi-
thelial cells of the kidney, whereas the Hh effectors (Gli1
and Gli2) are expressed in platelet-derived growth factor
receptor- (PDGFR-)-expressing interstitial pericytes
and perivascular fibroblasts. Both Ihh expression and
downstream Hh signaling were substantially activated
during renal fibrosis, as Hh-responsive pericytes and
perivascular fibroblasts proliferated and differentia-
ted into myofibroblasts. Hh ligand drove cell prolifera-
tion in a pericyte-like cell line, suggesting that epithe-
lial-derived Hh ligands might direct mesenchymal cell
proliferation during renal fibrosis. Pharmacological in-
hibition of Smo completely suppressed Gli1 induction,
but it did not inhibit fibrosis, suggesting that Gli2,
whose induction was not inhibited, may be the more
important Gli effector in renal fibrosis.
Materials and Methods
Animal Experiments
All mouse studies were performed according to the ani-
mal experimental guidelines issued by the Animal Care
and Use Committee at Harvard University. Wild-typemice were from Charles River Laboratories (Wilmington,
MA); FVB/N mice were used for unilateral ureteral ob-
struction (UUO) and C57BL/6 mice were used for unilat-
eral ischemia reperfusion injury (UIRI) time course exper-
iments and quantitative PCR studies. Ptch1-nLacZ (JAX
Stock 003081), Gli1-nLacZ (JAX Stock 008211), Gli2-
nLacZ (JAX stock 007922), Shh-GFPCre (JAX Stock
005622), and R26-LacZ knock-in mice were purchased
from Jackson Laboratories (Bar Harbor, ME). To create
Ihh-nLacZ reporter mice, an Ihh-nLacZ reporter allele
was constructed and the Ihh locus targeted in the em-
bryonic stem cells, replacing most of the first exon of Ihh
with an NLS-LacZ-pA cassette (see Supplemental Figure
S1at http://ajp.amjpathol.org).
Mice of 8 to 12 weeks were anesthetized with pentobar-
bital sodium (60 mg/kg body weight) before surgery, and
body temperatures were controlled at 36.5 to 37.5°C
throughout all procedures. Each time point represents three
to five mice as indicated. For UUO, the left kidney was
exposed through a flank incision and the left ureter tied off
at the level of the lower pole with two 4.0 silk ties. Mice were
sacrificed 3 to 14 days after obstruction. For UIRI, the left
kidney was exposed through a flank incision, and the renal
pedicle was clamped with nontraumatic microaneurysm
clamps (Roboz Surgical Instrument Co., Gaithersburg, MD),
which were removed after 28 minutes. Reperfusion was
visually verified. Two hours after surgery, 1 mL of 0.9%NaCl
intraperitoneally was administered.
Tissue Preparation and Histology
Mice were anesthetized, euthanized, and immediately per-
fused via the left ventricle with ice-cold PBS for 1 minute.
Kidneys were either snap frozen or fixed in 4% paraformal-
dehyde on ice for 2 hours, then incubated in 30% sucrose
in PBS at 4°C overnight. OCT-embedded (Sakura Finetek,
Torrance, CA) kidneys were cryosectioned into 7-m sec-
tions. LacZ activity was measured on paraformaldehyde-
fixed frozen sections by standard 5-bromo-4-chloro-3-indo-
lyl--D-galactopyranoside (X-gal) staining for 1 to 6 days at
37°C, and counterstained with nuclear fast red and
mounted. To quantify nLacZ cell number, 100 images
were taken of the entire cortex (Gli1 and Ptch1), the inner
cortex (Ihh) or cortex and medulla (Gli2) of the midsagittal
kidney sections containing papilla from at least four different
animals; the number of positive cells were then counted in
each 100 image using a manual cell counter from ImageJ
(http://rsbweb.nih.gov/ij). Primary antibodies included rabbit
anti--galactosidase (MP Biomedicals, Solon, OH, Cat.
#55976, 1:2000), chicken anti-green fluorescent protein (Aves
Labs, Tigard, OR, Cat #GFP-1020, 1: 500), rat anti-PDGFR-
(eBioscience, San Diego, CA, Cat. #14–1402, 1:500), Cy3-
conjugated -smooth muscle actin (-SMA) (Sigma-Aldrich,
St. Louis, MO, Cat. #C6198, 1:500), rat anti-F4/80 (Abcam,
Cambridge, MA, Cat. #ab6640, 1:500), fluorescein isothiocya-
nate (FITC)-Lotus tetragonolobus lectin (Vector Labs, Burlin-
game, CA, Cat. #FL-1321, 1:500), rabbit anti-CD31 (Abcam,
Cat. #ab28364, 1:500), rabbit anti-aquaporin 2 (Abcam, Cat.
#ab15116, 1:500), fluorescein isothiocyanate (FITC)-conju-
gated Dolichos biflorus agglutinin (Vector Labs, Cat. # FL-
1031, 1:500), and rabbit anti-NKCC2 (Alpha Diagnostic,
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bodies were either FITC or Cy3-conjugated (Jackson Immu-
noResearch, West Grove, PA) incubated for 30 minutes, with
DAPI nuclear counterstain followed by mounting in Prolong-
Gold (Invitrogen, Carlsbad, CA). Images were obtained by
confocal (Nikon C1 eclipse, Nikon, Melville, NY) or standard
microscopy (Nikon eclipse 90i, Nikon). Anti-LacZ antibodies
reliably labeled LacZ-expressing interstitial cells, although the
autofluorescence in tubular epithelia blunted their sensitivity in
tubular epithelial cells. Therefore, in certain situations X-gal
staining followed by indirect immunofluorescence was per-
formed with pseudocoloring of the X-gal stain.
Cell Culture Experiments
10T1/2 cells (ATCC) were grown in Basal Media Eagle
(Gibco, Billings, MT) with 10% fetal bovine serum sup-
plemented with penicillin and streptomycin and 2 mmol/L
glutamine. Shh conditioned media was generated from
supernatants of Cos7 cells stably transfected with
pcDNA3-N-Shh or pcDNA3 control plasmid. For pro-
pidium iodide cell cycle analysis and Bromodeoxyuridine
(BrdU) uptake cell proliferation assays, cells were grown
on 6 well plates, serum starved by incubating in 0.5%
fetal bovine serum for 12 hours, and then stimulated for
24 hours with either Shh conditioned media, Cos7 control
media, 500 nmol/L smoothened agonist (SAG) (Santa
Cruz, Santa Cruz, CA, Cat. #sc-202814) or water control
in 0.5% or 10% fetal bovine serum. For the BrdU uptake
assay, the cells were incubated in 10 m BrdU for 2
hours before harvesting and then stained using the BrdU-
FITC flow kit (BD Pharmingen, San Diego, CA). For the
cell cycle analysis, cells were fixed in ice-cold 100%
ethanol, incubated with propidium iodide (400 g/mL
propidium iodide, 2 mmol/L MgCl2, 100 mg/mL RNase),
and subject to fluorescence-activated cell sorting (FACS)
analysis.
IPI-926 Experiments
IPI-926 (5 mg/mL) stock solution (Infinity Pharmaceuti-
cals, Cambridge, MA) was prepared fresh for each ex-
periment by dissolving in hydroxyproplyl--cyclodextrin
(vehicle) and sonicating. Mice were given 40 mg/kg body
weight IPI-926 or vehicle by gastric lavage daily until the
day before sacrifice, with Gli1-LacZ mice receiving their
first dose the day before UUO surgery and being sacri-
ficed on day 7 of UUO, and BALB/c and C57BL/6 mice
receiving their first dose 2 days before UUO surgery and
being sacrificed on day 10 of UUO.
Western Blot
To confirm the presence of Shh in conditioned media by
Western blot, 5 L of conditioned media was first separated
by 10% polyacrylamide gel electrophoresis. To determine
the relative amount of -SMA protein in kidneys from IPI-
926- versus vehicle-treated mice, the lower kidney pole
from UUO and contralateral (CLK) kidneys were homoge-
nized in radioimmunoprecipitation assay buffer with pro-
tease inhibitors using a handheld rotor, the total proteinquantified by Bradford Assay and 25 g separated by 10%
polyacrylamide gel electrophoresis. Proteins were trans-
ferred to polyvinylidene difluoride membrane, blocked in
5% milk in phosphate buffered saline tween 20, probed
overnight at 4°C with goat anti-Shh-N antibody (Santa Cruz,
Cat. #sc-1194, 1:200) or mouse anti--SMA (Sigma-Aldrich,
Cat. #A2547, 1:5000), or for 1 hour at room temperature with
mouse anti-glyceraldehydes-3-phosphate dehydrogenase
(Abcam, Cat. #ab9484, 1:5000), washed, probed with anti-
goat- or mouse-horseradish peroxidase (Dako, Carpinteria,
CA, 1:5000) for 1 hour at room temperature, and the antigen
antibody complex was visualized using the ECL detection
system (PerkinElmer, Waltham, MA).
Real-Time PCR
RNA was extracted from snap-frozen tissue stored at
80°C or cells using standard techniques (RNeasy, Qia-
gen, Germantown, MD). Reverse transcription was per-
formed with the iScript cDNA synthesis kit (Bio-Rad, Her-
cules, CA) producing cDNA. Real-time PCR was
performed using iQ-SYBR Green supermix (BioRad) and
the iQ5 Multicolor Real-Time PCR Detection system (Bio-
Rad) for detection of mRNA levels. Glyceraldehydes-3-
phosphate dehydrogenase was used as the internal con-
trol.
Statistical Analysis
Statistical analyses were performed using Graph Pad
Prism software (version 5.0) (GraphPad Software, Inc.,
San Diego, CA). Analysis of variance was used to com-
pare data among groups followed by a Tukey’s post test
to compare all groups to each other or a Dunnett’s post
test to compare all groups to the control group. A two-
tailed Student’s t-test was used when only two groups
were being compared. All results were repeated at least
twice. A P value of less than 0.05 was considered signif-
icant. The results are presented as mean  SEM.
Results
Hh Ligands, Shh, and Ihh are Expressed in
Tubular Epithelial Cells
To define the expression pattern of Hh pathway members
in renal fibrosis, we used available Ptch1-nLacZ, Gli1-
nLacZ, and Gli2-nLacZ reporter mice, and generated
Ihh-nLacZ knockin reporter mice. Because Shh-GFPCre
reporter mice exhibited unexpectedly low green fluores-
cent protein fluorescence, historical Shh expression was
assessed in Shh-GFPCre; R26-LacZ bigenic mice, in
which cytoplasmic LacZ expression marks cells that ei-
ther actively express Shh or expressed Shh at one time in
development (see Supplemental Figure S2 at http://
ajp.amjpathol.org). LacZ expression in kidney sections
from Shh-GFPCre; R26-LacZ adult mice was present ex-
clusively in the papilla, corresponding to in situ hybridiza-
tion staining of Shh mRNA in P1 kidney (Figure 1A), as
well as ureteral urothelium (see Supplemental Figure S3
riance
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in Shh-GFPCre; R26-LacZ kidneys was localized to aqua-
porin 2 positive collecting ducts (Figure 2A; see also Sup-
plemental Figure S4 at http://ajp.amjpathol.org).
We generated Ihh-nLacZ knockin mice to report Ihh ex-
pression (see Supplemental Figure S1 at http://ajp.
amjpathol.org). Ihh was expressed predominantly in the in-
ner cortex and outer medulla at the corticomedullary junc-
tion, with reduced expression seen throughout the rest of
the medulla (Figure 1A). In situ hybridization in P1 mouse
kidneys confirmed staining in the outer medulla (Figure 1A),
consistent with previous findings during mouse develop-
ment.3 As with Shh, Ihh was exclusively expressed in tubu-
lar epithelial cells (Figure 2B). Most Ihh-nLacZ tubular cells
in the inner cortex and outer medulla co-stained with the
proximal tubular marker Lotus tetragonolobus lectin (Figure
2B; see also Supplemental Figure S4 at http://ajp.amjpathol.
org), consistent with a previous report of Ihh expression in
dissected proximal tubules by real-time PCR.19 In addition,
occasional Ihh-nLacZ was observed in thin limbs of Henle
(see Supplemental Figure S5A at http://ajp.amjpathol.org),
demonstrating Ihh expression of tubular epithelial cells with
squamous morphology lacking brush borders. These cells
Figure 1. Expression pattern of the Hedgehog (Hh) pathway in the mo
Ptch1-nLacZ, Gli1-nLacZ, and Gli2-nLacZ adult mice), in situ hybridization, a
In situ results are from P1 kidney; reporter mouse and quantitative PCR are
is expressed in inner cortex and medulla (m), and Ptch1 is expressed in co
exhibit prominent staining at the corticomedullary junction. B: Gli1 and G
Ptch1, was highest at the corticomedullary junction, whereas Gli2 was
differences in regional expression for all Hh pathway members: Shh,
throughout. *P  0.05, **P  0.005, and ***P  0.001 by analysis of va
medullopapillary junctions. Scale bar  50 m.did not costain with collecting duct markers aquaporin 2 orDilochus biflorus agglutinin, the thick ascending limb
marker Na-K-2Cl cotransporter or the endothelial marker
CD31 (see Supplemental Figure S5B at http://ajp.amjpathol.
org). Relative mRNA expression as determined by quanti-
tative PCR from dissected kidney cortex, medulla, and pa-
pilla confirmed that Shh is the most highly expressed Hh
ligand in the papilla, and Ihh is the most highly expressed
ligand in the medulla and cortex. Dhh expression was min-
imal (Figure 1C).
The Hh Receptor Ptch1 and Downstream
Effectors Gli1 and Gli2 are Expressed in
Interstitial Pericytes and Perivascular Fibroblasts
To define the cell types that respond to Hh ligand, we
examined the expression patterns of Ptch1 and Gli effec-
tors in the adult kidney. Ptch1 and Gli1 are readouts of Hh
pathway activity, and their expression defines Hh-re-
sponsive cells. Gli2 lies directly upstream of Gli1 and
other Hh transcriptional targets.1 Ptch1 (Figure 1A) and
Gli1 (Figure 1B) were expressed strongly at the cortico-
medullary junction, suggesting that these cells may be
ney. Reporter mice sonic hedgehog (Shh)-GFPCre; R26-LacZ Ihh-nLacZ,
titative PCR were used to measure and localize the Hh pathway expression.
e adult. A: Shh is observed only in the papilla (p) and ureter (arrow). Ihh
, medulla, and papilla. Both Indian hedgehog (Ihh) and Patched1 (Ptch1)
expressed in cortex, medulla, and papilla though Gli1, similar to Ihh and
in the inner medulla and papilla. C–E: Quantitative PCR confirms the
ert hedgehog (Dhh) (C); Ptch1 (D); Gli1, GLi2, Gli3 (E). N  3 mice
followed by Tukey’s post test. Dotted lines mark corticomedullary anduse kid
nd quan
from th
rtex (c)
li2 are
highest
Ihh, desresponding to Ihh in that region, whereas Gli2 (Figure 1B)
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papilla. Ptch1 and a lesser amount of Gli1 expression
was observed in the inner medulla and papilla as well,
likely in response to Ihh in the inner medulla and Shh in
the papilla. In situ studies of Ptch1 in P1 kidney sections
were consistent with Ptch1-nLacZ expression in adult
mice (Figure 1A) and embryonic kidney.20 Ptch1 was
also expressed in occasional tubular epithelial cells, glo-
merular cells, and endothelial cells, in addition to inter-
stitial cells (Figure 2C; see also Supplemental Figure S6
at http://ajp.amjpathol.org). In contrast, Gli1 and Gli2 were
exclusively expressed in interstitial cells in the adult kidney
(Figure 2C). Though there has been a prior report of Gli1
Figure 3. Expression of Gli2, but not Gli1, occurs in the epithelial cells of the ure
D-galactopyranoside (X-gal) staining of kidneys fromGli1-nLacZmice is exclusively
B: X-gal staining of kidneys fromGli2-nLacZmice reveals staining of ureteric bud epithelium
is decreased (arrows) in kidneys from 7-day-old mice (P7) and is almost completely absenexpression in tubules, especially in the setting of decreased
transcriptional repressor Glis2,21 we did not observe X-gal
staining of tubular epithelial cells using our Gli1-nLacZ re-
porter mouse, even in kidneys from newborn and 7-day-old
mice (Figure 3A). We did, however, observe X-gal staining
of epithelial cells in the ureteric bud in the nephrogenic zone
in kidneys from Gli2-nLacZ newborn mice that was de-
creased in kidneys from 7-day-old mice and almost com-
pletely absent in kidneys from 14-day-old mice (Figure 3B).
A higher density of Ptch1, Gli1, and Gli2-positive interstitial
cells were observed closely associated with vessels (Figure
2C, bottom three panels). Quantitative mRNA comparisons
confirmed that Ptch1 and Gli2 were most prominently ex-
Figure 2. Hedgehog (Hh) ligands are expressed in tubular epithelial cells,
and intersititial cells respond to Hh ligands. High-powered images of LacZ
expression and in situ hybridization reveal that sonic hedgehog (Shh) and
Indian hedgehog (Ihh) expression is restricted to tubular epithelial cells. A:
5-bromo-4-chloro-3-indolyl--D-galactopyranoside (X-gal) staining of Shh-
GFPCre; R26-LacZ kidney with subsequent immunofluorescent detection of
aquaporin 2 (AQP2) demonstrates that Shh is expressed in the collecting
duct. B: In the outer medulla, Ihh-positive cells have a cuboidal morphology
(arrows) and co-stain with the proximal tubular marker Lotus tetragonolo-
bus lectin (LTL). C: Patched1 (Ptch1)-nLacZ expression is present in the
glomerulus (g), tubules (t), endothelium (arrows), and interstitium (arrow-
heads), whereas Gli1-nLacZ and Gli2-nLacZ expression was restricted to
interstitial cells. Ptch1, Gli1 and Gli2-positive cells were enriched in the
perivascular space around arteries and arterioles (lower three panels). Scale
bar  50 m. nLacZ, nuclear lacZ.
in the nephrogenic zone of developing kidneys. A: 5-bromo-4-chloro-3-indolyl--
l and does not reveal staining of ureteric bud epithelium (arrow) in P0 and P7mice.teric bud
interstitia(arrows) in the outer cortex in newborn mice (P0). X-gal staining in epithelial cells
t in kidneys from 14-day-old mice (P14). Scale bar  50 m. nLacz, nuclear LacZ.
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highest in the medulla (Figure 1, D and E). Gli3 was also
highest in the medulla and papilla (Figure 1E), and was
expressed the highest overall when comparing the three Gli
effectors in kidney.
Hh Pathway Upregulation in Renal Fibrosis
To investigate Hh pathway modulation during renal fibrosis,
wemeasuredmRNA expression of Hh pathwaymembers in
corticomedullary kidney lysates from adult mice after 3, 7,
and 14 days of chronic injury by UUO compared to sham
controls. Expression of the fibrotic marker Collagen 11
(Col11) and the myofibroblast marker -SMA progres-
sively increased relative to sham, confirming fibrosis (Figure
4A). A progressive increase in Gli1 and Gli3 mRNA expres-
sion occurred on days 3, 7, and 14 of UUO, and a progres-
sive increase in Gli2 mRNA expression occurred on days 7
and 14 (Figure 4C). Gli1 and Gli3 demonstrated a morerobust induction relative to sham with a 13.6  4.3-fold
increase in Gli1 and a 15.2  5.7-fold increase in Gli3 on
day 14 versus a 3.5  1.9-fold increase in Gli2. Gli1 tran-
scription reflects active Hh signaling, and because of this,
the results indicate that the Hh pathway is activated during
renal fibrosis. Ptch1 expression also increased (Figure 4B),
although only by 2.1 0.4-fold, perhaps reflecting its stron-
ger baseline expression compared to Gli1.
Next, we asked which Hh ligand might account for
increased Hh signaling. Shh expression did not change
during UUO, although Ihh was induced transcriptionally,
peaking at day 3 with a 4.5  0.5 fold increase and
remained elevated thereafter (Figure 4D). A similar 3.4 
0.8 increase in Ihh mRNA at UUO day 3 was observed in
a second independent experiment (N  5). Dhh was also
increased relative to sham at all time points, although the
absolute amount of Dhh was extremely low -35.5  3.7-
fold lower than Ihh mRNA levels, indicating that Ihh is the
Figure 4. The Hedgehog (Hh) pathway is activated in two
different models of kidney fibrosis. A–D: Corticomedullary
lysates were obtained on days 3, 7, and 14 after unilateral
ureteral obstruction (UUO) or sham surgery, and mRNA
expression was normalized to glyceraldehydes-3-phosphate
dehydrogenase (GADPH). Collagen 11 (Col11) and
-smooth muscle actin (-SMA) (A) increased during UUO,
confirming fibrosis. Patched1 (Ptch1) (B) increased slightly
by day 14 of UUO. Gli1 and Gli3 levels (C) progressively rose
throughout UUO, and Gli2 levels increased on days 7 and 14.
Indian hedgehog (Ihh) (D) significantly increased after UUO,
peaking at day 3, whereas sonic hedgehog (Shh) and desert
hedgehog (Dhh) were minimally expressed. N 5 UUO and
5 sham mice per time point. E–H: Medullary lysates for
fibrotic markers, Gli1, Gli2, Gli3, and Ptch1, and cortical
lysates for Ihh were obtained on days 3, 7, 14, and 28 after
ischemia reperfusion injury (UIRI), or day 3 after sham sur-
gery. mRNA expression was normalized to GAPDH. Similar
to the peak increase of Col11 and -SMA at day 7 (E), Gli1,
Gli2, Gli3 (G), Ihh (H), and to a lesser degree Ptch1 (F),
increase after UIRI with a peak at day 7. Gli1 also exhibits a
second peak on day 28. N  4 mice for UIRI days 1, 3, 14,
and 28, and N  3 mice for UIRI day 7 and sham. *P  0.05,
**P  0.005, and ***P  0.001 by analysis of variance fol-
lowed by Dunnett’s post test.primary Hh ligand induced by chronic renal injury. To
point f
idney; n
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tigated a second model of renal fibrosis, unilateral isch-
emia reperfusion injury. UIRI has been validated as a
model of renal fibrosis in previous reports22 and a dra-
matic increase in -SMA immunofluorescent staining in
UIRI day 14 kidneys compared to CLK provided further
confirmation that a robust fibrotic response was achieved
(see Supplemental Figure S7 at http://ajp.amjpathol.org).
In this model, Ptch1, Gli1, Gli2, and Gli3 mRNA were all
significantly increased in medullary kidney lysates rela-
tive to sham, with peak levels observed on day 7 in
parallel with the peak increase in expression of Col11
and -SMA (Figure 4, E–G). Medullary lysates did not
show an increase in Ihh (data not shown), although Ihh
Figure 5. During unilateral ureteral obstruction (UUO) the number of Gli1, G
from 5-bromo-4-chloro-3-indolyl--D-galactopyranoside (X-gal) staining of k
with increasing duration of UUO. B: Higher-power images of boxed areas
Quantification of the number of Gli1-nLacZ-positive cells in the kidney cortex
an increase in the number of X-gal-positive interstitial cells in 7-day UUO
expression remains restricted to tubules in both uninjured and UUO kidneys.
and medulla, although the increase in the cortex is not as dramatic as that s
the interstitium, but not the tubules. Ihh-nLacZ mice do not show an increa
UUO. N  4 mice per time point for Gli1 and Ptch1, and N  3 mice per time
by analysis of variance followed by Dunnett’s post test. CLK, contralateral kwas increased at all time points in cortical lysates with apeak increase of 3.9  0.3 at day 7 (Figure 4H). Hh
pathway, therefore, is activated in two separate mouse
models of kidney fibrosis.
Myofibroblasts Respond to Hh Signals during
Fibrosis
To further define the cells that respond to Hh ligands, we
quantitated tubular versus interstitial expression of Gli1,
Gli2, and Ptch1 during UUO. Gli1 and Gli2 remained
exclusively expressed in the interstitium in UUO kidneys
without detectable tubular expression (Figure 5, B and
D). Compared to uninjured kidneys, cortical Gli1-nLacZ
Patched1 (Ptch1)-expressing cells increases. A: Low-power images of cortex
ections from Gli1-nLacZ mice show a progressive increase in X-gal staining
demonstrate that Gli-nLacZ-positive cells remain exclusively interstitial. C:
substantial increase during UUO. D: X-gal staining for Gli2 and Ptch1 shows
compared to uninjured kidneys. X-gal staining for Indian hedgehog (Ihh)
umber of Gli2-expressing cells per 200 field of view increases in the cortex
Gli1. Ptch1-expressing cells per 100 field of view of the cortex increase in
number of X-gal-positive cells per 100 field of view in the cortex during
or Gli2 and Ihh. Scale bar  50 m. *P  0.05, **P  0.005, and ***P  0.001
LacZ, nuclear LacZ.li2, and
idney s
from A
shows a
kidneys
E: The n
een for
se in thecells increased by 4.1  1.1-fold at 3 days, 10.5 
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AJP April 2012, Vol. 180, No. 41.8-fold at 7 days, and 10.7  0.8-fold at 14 days after
UUO (Figure 5, A–C). The number of LacZ-expressing
cells in Gli2-nLacZ mice increased as well, but to a lesser
degree, with only a 1.7  0.3 increase in the cortex and
Figure 6. Gli1, Gli2, and Patched1 (Ptch1)-positive interstitial cells co-exp
acquire expression of the myofibroblast marker -smooth muscle actin (-SM
cell-types express Gli1, Gli2, and Ptch1 in uninjured and injured kidneys, da
Ptch1-nLacZ mice were immunofluorescently co-labeled for nLacZ and vario
nLacZ in interstitial cells from all three reporter mice colocalized with the percontact with cells expressing the macrophage marker F4/80 and endothelial marker C
(insets) for CLK and UUO. nLacZ, nuclear LacZ.3.9  0.5 increase in the medulla (Figure 5, D and E; see
also Supplemental Figure S8A at http://ajp.amjpathol.org).
There was a 1.9  0.5-fold decrease in the number of
Ptch1-nLacZ tubular epithelial cells, but there was a 4.1
pericyte marker platelet-derived growth factor receptor- (PDGFR-) and
nilateral ureteral obstruction (UUO) kidneys. To determine which interstitial
and contralateral (CLK) kidney sections from Gli1-nLacZ, Gli2-nLacZ, and
pe specific markers and pictures were obtained from the inner renal cortex.
rker PDGFR- in both CLK (arrows) and UUO kidneys. nLacZ in interstitialress the
A) in u
y 7 UUO
us cell-ty
icyte ma
cells for all three reporter mice colocalized with the myofibroblast marker -SMA in the UUO kidneys. Gli1, Gli2, and Ptch1-expressing cells often come into close
D31, although the vast majority of these cells do not co-express these markers
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AJP April 2012, Vol. 180, No. 4 0.6-fold increase in the number of Ptch1-nLacZ inter-
stitial cells (Figure 5, D and E; see also Supplemental
Figure S8B at http://ajp.amjpathol.org). In contrast with
the transcriptional induction of Ihh observed during renal
fibrosis, there was no increase in the number of Ihh-
nLacZ cells in UUO. Ihh-nLacZ expression remained lo-
calized to tubular epithelial cells in the inner cortex and
outer medulla after UUO (Figure 5, D and E; see also
Supplemental Figure S8C at http://ajp.amjpathol.org).
Thus, the increase in Ihh mRNA expression was not due
to an increase in the number of Ihh expressing cells at the
level of sensitivity of the Ihh-nLacZ reporter.
During development, epithelial-derived Hh regulates
mesenchymal proliferation and differentiation; we there-
fore sought to more precisely define the interstitial cell
type that was responding to Hh signals and asked
whether these cells were proliferating during renal fibro-
sis. A protocol for detection of nuclear LacZ by immuno-
fluorescence was developed for this purpose. Gli1-
nLacZ-positive cells uniformly co-expressed the pericyte
and perivascular fibroblast marker PDGFR- in both un-
injured and injured kidneys (Figure 6). In the fibrotic but
not uninjured kidney, Gli1-nLacZ-positive cells also ac-quire the myofibroblast marker -SMA (Figure 6). Macro-
phages and endothelial cells were often closely opposed
to Gli1-nLacZ-positive cells; there was, however, no over-
lap in the Gli1 expression domain among either of these
cell types (Figure 6). The close association between Gli1-
nLacZ-positive cells and endothelial cells is consistent
with the possibility that some or all of these cells are
pericytes. Gli2-nLacZ and Ptch1-nLacZ also colocalized
with PDGFR- in uninjured and injured kidneys, with the
majority of them co-expressing the myofibroblast marker
-SMA during injury, but not the macrophage marker
F4/80 or endothelial marker CD31 (Figure 6).
To investigate the correlation between Gli1 expression
and cell proliferation in UUO, Gli1-nLacZ expressing cells
were costained with the cell cycle marker Ki-67. Ki-67-
positive cells were observed in both tubules and in the
interstitium on day 3 of UUO. The percentage of Gli1-
nLacZ positive cells that were co-stained for Ki-67 was
12.6  1.2% compared to only 1.3  0.4% in uninjured
kidneys (Figure 7, A and B). These results indicate that
many Hh-responsive cells are proliferating in the early
stages of renal fibrosis.
Figure 7. Gli1-expressing cells undergo increased prolifer-
ation early in unilateral ureteral obstruction (UUO), and stim-
ulation of a pericyte-like cell line with Hedgehog (Hh) ago-
nists induces cell proliferation in vitro. A: To determine
whether proliferation of Gli1-expressing cells increases dur-
ing UUO, sections from days 0, 3, and 7 UUO kidneys from
Gli1-nLacZ mice were co-labeled for nLacZ and Ki-67. B: The
percentage of nLacZ-positive cells co-staining for Ki-67 was
determined by dividing the number of nLacZ; Ki-67 dou-
ble positive cells (arrows) by the total number of nLacZ-
positive cells in the outer medulla. Scale bar  25 m. N 
3 mice for days 0 and 7; N  4 mice for day 3. A greater
percentage of Gli1-nLacZ cells costained with Ki-67 at day 3
compared to days 0 and 7. C: Stimulation of 10T1/2 cells with
sonic hedgehog (Shh) ligand or smoothened agonist (SAG)
induces a large upregulation of Gli1 as assessed by quanti-
tative PCR. Platelet-derived growth factor (PDGF) and trans-
forming growth factor (TGF)- had no effect. D, E: 10T1/2
cells labeled with propidium iodine and analyzed by fluo-
rescence-activated cell sorting after stimulation with either
Shh (D), SAG (E), or 10% fetal bovine serum (FBS) show an
increase in the percentage of cells in SG2M and a decrease
in the percentage of cells in G1 compared to Cos7 control
media for Shh and water vehicle control for SAG. F, G: The
percentage of 10T1/2 cells positive for 5-bromo-2-deoxyuri-
dine (BrdU) uptake increases with stimulation with Shh (F),
SAG (G), or 10% FBS compared to Cos7 control media or
vehicle control. N  3 per condition. *P  0.05, ** P  0.005,
and ***P  0.001 by analysis of variance followed by Dun-
nett’s post test (B and D–G) and by two-tailed Student’s t-test
(C). nLacZ, nuclear LacZ.
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Progression in Pericyte-Like Cells
Next we asked whether Hh ligand could directly induce
proliferation of pericyte-like cells in vitro. The mouse mes-
enchymal cell line 10T1/2 is hedgehog-responsive and
multipotent,23 and it can be induced to differentiate into
-SMA mature pericytes by transforming growth factor-
.24 Kidney pericytes are -SMA negative but gain
-SMA expression as they differentiate into myofibro-
blasts during fibrosis,25 so we reasoned that 10T1/2 cells
might be a good model for uninjured kidney pericytes.
The presence of Shh in conditioned media from Cos7
cells stably transfected with pcDNA-N-Shh was con-
firmed by Western blot (see Supplemental Figure S9A at
http://ajp.amjpathol.org). Then we confirmed that the me-
dia containing Shh activates Gli1 expression in these
cells26,27 by 153.9  8.2-fold under our conditions. Con-
sistent with this, the Smo agonist SAG induced a 107.5 
6.2-fold increase in Gli1 gene expression (Figure 7C).
Gli2 and Gli3 were only minimally affected (see Supple-
mental Figure S9B at http://ajp.amjpathol.org). Neither
platelet-derived growth factor nor transforming growth
factor-, both increased in UUO, induced Gli1 expres-
sion (Figure 7C). Although 10T1/2 cells have been used
to model Hh-induced differentiation, the effect of Hh ago-
nists on cell proliferation in these cells has not been
reported. Hh pathway activation either with Shh or SAG
induced proliferation of serum-starved 10T1/2 pericytes,
as assessed by cell cycle analysis (Figure 7, D and E). In
confirmation of these results, Shh and SAG also stimu-
lated BrdU uptake as quantitated by FACS analysis (Fig-
ure 7, F and G). These in vitro results suggested that Hh
could drive pericyte proliferation during fibrotic injury and
are consistent with prior reports that Hh signaling can
regulate proliferation of mouse and human mesenchymal
cells in vitro.2,28
Pharmacological Inhibition of Hh Signaling Does
Not Attenuate Fibrosis
We next investigated the functional role of kidney Hh
signaling in vivo by pharmacological inhibition. Cyclo-
pamine is a well-characterized Smo inhibitor, buts its use
in vivo is limited by its short half life29 and off-target effects
at higher doses.30,31 We, therefore, used the cyclo-
pamine derivative IPI-926, which has the advantages of a
long half-life, increased potency, and oral bioavailabil-
ity.32 IPI-926 nearly completely abolished Gli1 induction
after 7 days of UUO, as reflected by the expression of
Gli1-nLacZ (Figure 8, A and B). The efficacy of IPI-926 in
inhibiting Hh signaling was further confirmed by quanti-
tative PCR from day 10 UUO corticomedullary kidney
extracts from BALB/c mice; the increase in Gli1 mRNA
expression seen in UUO kidneys from the vehicle-treated
mice was completely suppressed, and a decrease in the
CLK controls was also seen. Importantly, the increase in
Gli2 mRNA seen in UUO was not suppressed by IPI-926,
suggesting that the increase in Gli2 in this setting is not
smoothened dependent. Despite complete inhibition ofGli1 by IPI-926, there was no decrease in renal fibrosis, as
assessed by change in Col11, fibronectin, or -SMA gene
transcription, or -SMA protein levels by Western blot at
Figure 8. IPI-926 inhibits Hedgehog (Hh) signaling in unilateral ureteral
obstruction (UUO) kidneys. A: To determine whether IPI-926 inhibits Hh
signaling, IPI-926 (40 mg/kg) (N  5) or vehicle (N  5) was given daily by
gastric lavage for 8 days to Gli1-nLacZ mice starting the day before UUO.
Mice were sacrificed on UUO day 7. B: The increase in cortical 5-bromo-4-
chloro-3-indolyl--D-galactopyranoside (X-gal) staining seen in UUO kidney
sections from vehicle-treated Gli1-nLacZ mice compared to contralateral
kidney (CLK) is completely abolished in IPI-926-treated mice. C: mRNA
expression by quantitative PCR of Gli1, Gli2, Gli3, and Patched1 (Ptch1) from
UUO and CLK kidney lysates from BALB/c mice treated in a blinded fashion
with IPI-926 (N  6) or vehicle (N  8) shows inhibition of Gli1 expression
in CLK and UUO. The increase in Gli2 and Gli3 expression in UUO compared
to CLK was not inhibited by IPI-926. BALB/c mice were sacrificed on UUO
day 10 and treated daily with IPI-926 40 mg/kg or vehicle for 12 days starting
2 days before surgery. *P  0.05, **P  0.005, and ***P  0.001 by two-tailed
Student’s t-test.UUO day 10 (Figure 9, A and B). In a blinded assessment
-926-trea
O. ns, n
Hedgehog Pathway in Renal Fibrosis 1451
AJP April 2012, Vol. 180, No. 4of interstitial fibrosis/tubular atrophy percentage by
trichome stain at UUO day 10, there also showed no
difference between IPI-926 and vehicle-treated groups.
These experiments establish that Gli1 induction in this
model is mediated by Hh ligand, but Gli1 does not me-
diate renal fibrosis in this model.
Discussion
Activation of canonical Hh signaling in mesenchymal
cells during tissue injury has been recently observed in
the bladder, liver, and lung.12,13,16 That scar-forming
myofibroblasts derive from mesenchymal progenitors in
the kidney,17,25 supporting the hypothesis tested here
that Hh-Gli signaling is reactivated in renal fibrosis and
that myofibroblasts and their progenitors responds to Hh
ligands. These findings also support the general concept
that kidney injury responses often reactivate develop-
mental signaling pathways,33 such as the Wnt,34 Notch,35
Figure 9. IPI-926 does not decrease renal fibrosis in unilateral ureteral obs
10 UUO corticomedullary kidney lysates from BALB/c mice did not decrease
to vehicle treatment (N 8). B: The increase in -smooth muscle actin (-SM
by Western blot and quantified by integrated optical density (IOD) -SMA
IPI-926-treatment. C and D: Trichome stains (C) of UUO day 10 kidney secti
percentage (IF/TA%) by a pathologist did not show a difference between IPI
daily IPI-926 (40 mg/kg) or vehicle for 12 days beginning 2 days before UUand fibroblast growth factor pathways.36Our results confirm that in the uninjured kidney, Ihh-
producing cells are localized to outer medullary tubular
epithelia and Shh expression is restricted to papillary
collecting duct.3,19 Most Ihh-producing cells were in
proximal tubule, with some expression in thin limbs of
Henle. Expression of Ptch1 and Gli1 is strongest in med-
ullary stroma during development4 and consistent with
this, their expression was strongest in the outer medulla
of the adult kidney. Ihh induction drives Ptch1 and Gli1
expression in cortex and medulla during fibrosis, be-
cause it is expressed in adjacent tubular epithelium, and
because Gli1 induction was completely inhibited by the
Smo inhibitor IPI-926. The epithelial localization of both Ihh
and Shh in the kidney, combined with our demonstration of
stromal expression of Gli1 and Gli2 in renal interstitium,
indicates that Hh is acting in a paracrine fashion in kidney
fibrosis, as it does during renal development.3,20
We observed transcriptional induction of Ihh in renal
fibrosis but nontranscriptional mechanisms may also
(UUO). A: mRNA expression by quantitative PCR of fibrotic markers in day
days of IPI-926 treatment (N  6) initiated 2 days before surgery compared
in expression in UUO compared to contralateral kidney (CLK) as determined
yceraldehydes-3-phosphate dehydrogenase (GAPDH) was not inhibited by
C57BL/6 mice and blindly scored (D) for interstitial fibrosis/tublar atrophy
ted (N  6) and vehicle-treated groups (N  7). C57BL/6 mice also received
onsignificant by two-tailed Student’s t-test.truction
with 12
A) prote
/IOD gl
ons fromcontribute to Hh pathway activation in target cells. Re-
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to occur from peripheral nerves in skin,37 and whether
such a mechanism operates in the kidney remains to be
tested. Smo inhibition did not decrease fibrosis, although
redundant pathways for myofibroblast proliferation may
exist in this model. Equally important, although Smo inhi-
bition inhibited Gli1 induction, it did not suppress Gli2
induction. Gli1 and Gli2 can have redundant roles them-
selves,38 and Gli1 is dispensable for many Hh effector
functions.39 Our results, therefore, indicate that Gli2
might be the more important Gli effector in renal fibrosis.
Recently, evidence indicates that other signaling path-
ways may sensitize target cells to Hh ligand40 or induce
ligand-independent, noncanonical Hh pathway activa-
tion. Both the RAS-RAF-MEK and PI3K/AKT pathways
can potentiate Gli1 function or activate Gli signaling in-
dependent of Smo,40–42 and both of these pathways are
implicated in renal myofibroblast activation.43–45 Trans-
forming growth factor-, whose critical role in renal fibro-
sis is well described,46 can also activate Gli2 expression
independent of Ptch1/Smo in human fibroblasts47 and in
cancer.48 Whether noncanonical, Smo-independent Gli
activation occurs in kidney fibrosis, and defining the ex-
tent to which other more established pro-fibrotic path-
ways might modulate Hh-Gli signaling in the adult kidney
are critical questions that require further investigation.
The functional role of Hh-Gli signaling in renal peri-
cytes, perivascular fibroblasts, and myofibroblasts in vivo
remains to be defined. Our in vitro evidence suggested
the hypothesis that Hh signaling might contribute to mes-
enchymal cell proliferation during injury, consistent with
its known role in regulating ureteral stromal cell prolifer-
ation during development. Our in vivo data, however, do
not support this model. Other roles for Hh signaling in
renal injury responses are also possible. Hh can drive
pro-angiogenic signaling in mesenchymal cells after in-
jury49 or during carcinogenesis.50 Whether Hh-mediated
pro-angiogenic signaling might occur in either acute or
chronic injury is an interesting possibility because angio-
genic signals are important in both diseases.51,52 An-
other question raised by these studies is why Gli1, Gli2,
and Ptch1 are expressed in only some myofibroblasts.
Are the Hh-responsive pericytes and perivascular fibro-
blasts different from their neighboring stromal cells? A
growing literature documents Hh pathway activation in
mesenchymal stem cell biology,28 and Hh is classically
known as a stem cell-promoting factor.37,53 In the future it
will be important to define possible functional differences
between Gli1-positive and Gli1-negative interstitial cells.
Finally, strong evidence implicates cortical Gli3 repressor
function in regulating ureteric tip gene expression and
patterning during renal development.20 The activation of
Hh signaling in cortex that we report here suggests that
the balance of Gli activator and repressor forms may be
altered during kidney injury.
In summary, we demonstrate, for the first time, strong
activation of the Hh-Gli pathway during renal fibrosis.
Chronic injury induces Ihh expression, which acts in a
paracrine fashion on interstitial pericytes and perivas-
cular fibroblasts to activate Gli effector expression.
These findings define the Hh-Gli pathway as a noveldevelopmental signaling pathway that is strongly up-
regulated in renal fibrosis. Future studies are required
to define the functional roles of Gli effector proteins in
kidney fibrosis.
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